These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37359514)

  • 1. Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection.
    Maina TW; Grego EA; Broderick S; Sacco RE; Narasimhan B; McGill JL
    Front Immunol; 2023; 14():1186184. PubMed ID: 37359514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.
    McGill JL; Kelly SM; Kumar P; Speckhart S; Haughney SL; Henningson J; Narasimhan B; Sacco RE
    Sci Rep; 2018 Feb; 8(1):3021. PubMed ID: 29445124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine safety and efficacy evaluation of a recombinant bovine respiratory syncytial virus (BRSV) with deletion of the SH gene and subunit vaccines based on recombinant human RSV proteins: N-nanorings, P and M2-1, in calves with maternal antibodies.
    Blodörn K; Hägglund S; Fix J; Dubuquoy C; Makabi-Panzu B; Thom M; Karlsson P; Roque JL; Karlstam E; Pringle J; Eléouët JF; Riffault S; Taylor G; Valarcher JF
    PLoS One; 2014; 9(6):e100392. PubMed ID: 24945377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves.
    McGill JL; Kelly SM; Guerra-Maupome M; Winkley E; Henningson J; Narasimhan B; Sacco RE
    Sci Rep; 2019 Oct; 9(1):15157. PubMed ID: 31641172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Lasting Protection Induced by a Polyanhydride Nanovaccine against Respiratory Syncytial Virus in an Outbred Mouse Model.
    Stephens LM; Ross KA; McLellan JS; Narasimhan B; Varga SM
    J Virol; 2022 Nov; 96(22):e0150222. PubMed ID: 36314826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against bovine respiratory syncytial virus in calves vaccinated with adjuvanted modified live vaccine administered in the face of maternal antibody.
    Kolb EA; Buterbaugh RE; Rinehart CL; Ensley D; Perry GA; Abdelsalam KW; Chase CCL
    Vaccine; 2020 Jan; 38(2):298-308. PubMed ID: 31668818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
    Taylor G; Thom M; Capone S; Pierantoni A; Guzman E; Herbert R; Scarselli E; Napolitano F; Giuliani A; Folgori A; Colloca S; Cortese R; Nicosia A; Vitelli A
    Sci Transl Med; 2015 Aug; 7(300):300ra127. PubMed ID: 26268314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intranasal recombinant NDV-BRSV F
    Sacco RE; Mena I; Palmer MV; Durbin RK; García-Sastre A; Durbin JE
    Sci Rep; 2022 Dec; 12(1):22552. PubMed ID: 36581658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new subunit vaccine based on nucleoprotein nanoparticles confers partial clinical and virological protection in calves against bovine respiratory syncytial virus.
    Riffault S; Meyer G; Deplanche M; Dubuquoy C; Durand G; Soulestin M; Castagné N; Bernard J; Bernardet P; Dubosclard V; Bernex F; Petit-Camurdan A; Deville S; Schwartz-Cornil I; Eléouët JF
    Vaccine; 2010 May; 28(21):3722-34. PubMed ID: 20307593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.
    Antonis AF; van der Most RG; Suezer Y; Stockhofe-Zurwieden N; Daus F; Sutter G; Schrijver RS
    Vaccine; 2007 Jun; 25(25):4818-27. PubMed ID: 17499893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves.
    Ellis JA; Gow SP; Mahan S; Leyh R
    J Am Vet Med Assoc; 2013 Dec; 243(11):1602-8. PubMed ID: 24261811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration.
    Ellis J; Gow S; West K; Waldner C; Rhodes C; Mutwiri G; Rosenberg H
    J Am Vet Med Assoc; 2007 Jan; 230(2):233-43. PubMed ID: 17223757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine model of respiratory syncytial virus infection.
    Taylor G
    Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine respiratory syncytial virus ISCOMs-Immunity, protection and safety in young conventional calves.
    Hägglund S; Hu K; Vargmar K; Poré L; Olofson AS; Blodörn K; Anderson J; Ahooghalandari P; Pringle J; Taylor G; Valarcher JF
    Vaccine; 2011 Nov; 29(47):8719-30. PubMed ID: 21864616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of bovine respiratory syncytial virus in calves.
    Guzman E; Taylor G
    Mol Immunol; 2015 Jul; 66(1):48-56. PubMed ID: 25553595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of local disease-sparing responses to bovine respiratory syncytial virus in intranasally vaccinated and challenged calves.
    Gray D; Ellis JA; Gow SP; Lacoste SR; Allan GM; Mooney MH
    J Proteomics; 2019 Jul; 204():103397. PubMed ID: 31146050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves.
    Ellis JA; Gow SP; Goji N
    J Am Vet Med Assoc; 2010 May; 236(9):991-9. PubMed ID: 20433400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus infections in human beings and in cattle.
    Van der Poel WH; Brand A; Kramps JA; Van Oirschot JT
    J Infect; 1994 Sep; 29(2):215-28. PubMed ID: 7806887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a single intranasal dose of modified-live bovine respiratory syncytial virus vaccine on resistance to subsequent viral challenge in calves.
    Woolums AR; Brown CC; Brown JC; Cole DJ; Scott MA; Williams SM; Miao C
    Am J Vet Res; 2004 Mar; 65(3):363-72. PubMed ID: 15027687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.